Therapeutic application of brain-specific angiogenesis inhibitor 1 for cancer therapy

Mitra Nair, Chelsea Bolyard, Tae Jin Lee, Balveen Kaur, Ji Young Yoo

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

Brain-specific angiogenesis inhibitor 1 (BAI1/ADGRB1) is an adhesion G protein-coupled receptor that has been found to play key roles in phagocytosis, inflammation, synaptogenesis, the inhibition of angiogenesis, and myoblast fusion. As the name suggests, it is primarily expressed in the brain, with a high expression in the normal adult and developing brain. Additionally, its expression is reduced in brain cancers, such as glioblastoma (GBM) and peripheral cancers, suggesting that BAI1 is a tumor suppressor gene. Several investigators have demonstrated that the restoration of BAI1 expression in cancer cells results in reduced tumor growth and angiogenesis. Its expression has also been shown to be inversely correlated with tumor progression, neovascularization, and peri-tumoral brain edema. One method of restoring BAI1 expression is by using oncolytic virus (OV) therapy, a strategy which has been tested in various tumor models. Oncolytic herpes simplex viruses engineered to express the secreted fragment of BAI1, called Vasculostatin (Vstat120), have shown potent anti-tumor and anti-angiogenic effects in multiple tumor models. Combining Vstat120-expressing oHSVs with other chemotherapeutic agents has also shown to increase the overall anti-tumor efficacy in both in vitro and in vivo models. In the current review, we describe the structure and function of BAI1 and summarize its application in the context of cancer treatment.

Original languageEnglish (US)
Article number3562
JournalCancers
Volume13
Issue number14
DOIs
StatePublished - Jul 2 2021
Externally publishedYes

Keywords

  • Brain-specific angiogenesis inhibitor 1 (BAI1)
  • Glioblastoma (GBM)
  • Oncolytic herpes simplex virus-1 (oHSV)
  • Vasculostatin (Vstat120)

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Therapeutic application of brain-specific angiogenesis inhibitor 1 for cancer therapy'. Together they form a unique fingerprint.

Cite this